Literature DB >> 8119988

Identification of a p53 binding site in the human retinoblastoma susceptibility gene promoter.

N E Osifchin1, D Jiang, N Ohtani-Fujita, T Fujita, M Carroza, S J Kim, T Sakai, P D Robbins.   

Abstract

p53 is a tumor suppressor gene found to be mutated in a wide variety of tumors. The encoded p53 protein has properties of a classical transcription factor, but the promoter targets for its regulation are largely unknown. We have investigated the ability of p53 to regulate activity of the human retinoblastoma susceptibility gene (Rb) promoter using a cotransfection assay in CCL-64 and Saos-2 cells. p53 was able to stimulate transcription from the Rb promoter at low input doses of p53 expression plasmid, whereas transcription was repressed at high input doses. The stimulatory effect of p53 on Rb promoter activity mapped to a region between 4 and 92 base pairs upstream from the start site of translation, whereas the region controlling repression by p53 mapped to the basal transcriptional control region of the promoter between -207 and -185. Moreover, an oligonucleotide containing Rb promoter sequences between -63 and -88 was sufficient to confer stimulation by p53 when inserted upstream from a minimal heterologous promoter. Gel mobility shift analysis was used to demonstrate that p53 can bind to a sequence within the -63 to -88 oligonucleotide with homology to a p53 binding site. The presence of a functional p53 binding site in the human retinoblastoma tumor suppressor gene promoter suggests that p53 can regulate Rb promoter activity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8119988

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  The muscle regulatory transcription factor MyoD participates with p53 to directly increase the expression of the pro-apoptotic Bcl2 family member PUMA.

Authors:  Terri J Harford; Greg Kliment; Girish C Shukla; Crystal M Weyman
Journal:  Apoptosis       Date:  2017-12       Impact factor: 4.677

2.  Transcriptional activation of the human epidermal growth factor receptor promoter by human p53.

Authors:  J H Ludes-Meyers; M A Subler; C V Shivakumar; R M Munoz; P Jiang; J E Bigger; D R Brown; S P Deb; S Deb
Journal:  Mol Cell Biol       Date:  1996-11       Impact factor: 4.272

3.  Direct interaction of the hepatitis B virus HBx protein with p53 leads to inhibition by HBx of p53 response element-directed transactivation.

Authors:  R Truant; J Antunovic; J Greenblatt; C Prives; J A Cromlish
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

4.  Regulation of RB transcription in vivo by RB family members.

Authors:  Deborah L Burkhart; Lynn K Ngai; Caitlin M Roake; Patrick Viatour; Chellappagounder Thangavel; Victoria M Ho; Erik S Knudsen; Julien Sage
Journal:  Mol Cell Biol       Date:  2010-01-25       Impact factor: 4.272

5.  p53 regulates myogenesis by triggering the differentiation activity of pRb.

Authors:  A Porrello; M A Cerone; S Coen; A Gurtner; G Fontemaggi; L Cimino; G Piaggio; A Sacchi; S Soddu
Journal:  J Cell Biol       Date:  2000-12-11       Impact factor: 10.539

6.  Effects of p53 mutants derived from lung carcinomas on the p53-responsive element (p53RE) of the MDM2 gene.

Authors:  V G Gorgoulis; P V Zacharatos; E Manolis; J A Ikonomopoulos; A Damalas; C Lamprinopoulos; G Z Rassidakis; V Zoumpourlis; A Kotsinas; A N Rassidakis; T D Halazonetis; C Kittas
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

7.  The transcription factor p53: not a repressor, solely an activator.

Authors:  Martin Fischer; Lydia Steiner; Kurt Engeland
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.